Effects of 14-alpha-lipoyl andrographolide on quorum sensing in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 12, 2012, Pages 6088-6094

  Ma, Li ^a   Liu, Xiangyang ^a   Liang, Haihua ^b   Che, Yizhou ^d   Chen, Caixia ^a   Dai, Huanqin ^a   Yu, Ke ^a   Liu, Mei ^a   Ma, Luyan ^a   Yang, Ching Hong ^d   Song, Fuhang ^a   Wang, Yuqiang ^c   Zhang, Lixin ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b NORTHWEST UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

14 ALPHA LIPOYL ANDROGRAPHOLIDE; ANDROGRAPHOLIDE; ANTIINFECTIVE AGENT; BETA GALACTOSIDASE; POLYSACCHARIDE; PSL POLYSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BIOFILM; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC REGULATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANDROGRAPHIS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-GALACTOSIDASE; BIOFILMS; BLOTTING, WESTERN; DITERPENES; DRUG SYNERGISM; GENE EXPRESSION REGULATION, BACTERIAL; INDICATORS AND REAGENTS; LUCIFERASES; MICROBIAL SENSITIVITY TESTS; POLYSACCHARIDES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; QUORUM SENSING; REAL-TIME POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 84869204065     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01119-12     Document Type: Article

References (63)

1. Allesen-Holm M, et al. 2006. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol. Microbiol. 59:1114-1128.
2. Bleves S, Soscia C, Nogueira-Orlandi P, Lazdunski A, Filloux A. 2005. Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAO1. J. Bacteriol. 187:3898-3902.
3. Borlee BR, Geske GD, Blackwell HE, Handelsman J. 2010. Identification of synthetic inducers and inhibitors of the quorum-sensing regulator LasR in Pseudomonas aeruginosa by high-throughput screening. Appl. Environ. Microbiol. 76:8255-8258.
4. Bull AT, Stach JE. 2007. Marine actinobacteria: new opportunities for natural product search and discovery. Trends Microbiol. 15:491-499.
5. Burrowes E, Abbas A, O'Neill A, Adams C, O'Gara F. 2005. Characterisation of the regulatory RNA RsmB from Pseudomonas aeruginosa PAO1. Res. Microbiol. 156:7-16.
6. Byrd MS, et al. 2009. Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production. Mol. Microbiol. 73:622-638.
7. Chen JX, et al. 2009. Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro. Biol. Pharm. Bull. 32:1385-1391.
8. Cowell BA, Twining SS, Hobden JA, Kwong MS, Fleiszig SM. 2003. Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells. Microbiology 149:2291-2299.
9. Cuesta G, Suarez N, Bessio MI, Ferreira F, Massaldi H. 2003. Quantitative determination of pneumococcal capsular polysaccharide serotype using a modification of phenol-sulfuric acid method. J. Microbiol. Methods 52:69-73.
10. Davies DG, et al. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-298.
11. Duan K, Surette MG. 2007. Environmental regulation of Pseudomonas aeruginosa PAO1 Las and Rhl quorum-sensing systems. J. Bacteriol. 189:4827-4836.
12. Fogerty MD, et al. 2008. Risk factors for pressure ulcers in acute care hospitals. Wound Repair Regen. 16:11-18.
13. Friedman L, Kolter R. 2004. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J. Bacteriol. 186:4457-4465.
14. Gilbert KB, Kim TH, Gupta R, Greenberg EP, Schuster M. 2009. Global position analysis of the Pseudomonas aeruginosa quorum-sensing transcription factor LasR. Mol. Microbiol. 73:1072-1085.
15. Govan JR, Deretic V. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
16. Hauser AR. 2009. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7:654-665.
17. Heeb S, Blumer C, Haas D. 2002. Regulatory RNA as mediator in GacA/RsmA-dependent global control of exoproduct formation in Pseudomonas fluorescens CHA0. J. Bacteriol. 184:1046-1056.
18. Heurlier K, et al. 2004. Positive control of swarming, rhamnolipid synthesis, and lipase production by the posttranscriptional RsmA/RsmZ system in Pseudomonas aeruginosa PAO1. J. Bacteriol. 186:2936-2945.
19. Hoang TT, Kutchma AJ, Becher A, Schweizer HP. 2000. Integration- proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Plasmid 43:59-72.
20. Hoang TT, Schweizer HP. 1999. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J. Bacteriol. 181:5489-5497.
21. Hogardt M, Roeder M, Schreff AM, Eberl L, Heesemann J. 2004. Expression of Pseudomonas aeruginosa exoS is controlled by quorum sensing and RpoS. Microbiology 150:843-851.
22. Irie Y, et al. 2010. Pseudomonas aeruginosa biofilm matrix polysaccharide Psl is regulated transcriptionally by RpoS and post-transcriptionally by RsmA. Mol. Microbiol. 78:158-172.
23. Jackson KD, Starkey M, Kremer S, Parsek MR, Wozniak DJ. 2004. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J. Bacteriol. 186:4466-4475.
24. Jensen SE, Fecycz IT, Campbell JN. 1980. Nutritional factors controlling exocellular protease production by Pseudomonas aeruginosa. J. Bacteriol. 144:844-847.
25. Jiang X, et al. 2009. Synthesis and evaluation of antibacterial activities of andrographolide analogues. Eur. J. Med. Chem. 44:2936-2943.
26. Karatan E, Watnick P. 2009. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol. Mol. Biol. Rev. 73:310-347.
27. Knight V, et al. 2003. Diversifying microbial natural products for drug discovery. Appl. Microbiol. Biotechnol. 62:446-458.
28. Kuchma SL, Connolly JP, O'Toole GA. 2005. A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa. J. Bacteriol. 187:1441-1454.
29. Liang H, Li L, Dong Z, Surette MG, Duan K. 2008. The YebC family protein PA0964 negatively regulates the Pseudomonas aeruginosa quinolone signal system and pyocyanin production. J. Bacteriol. 190:6217-6227.
30. Lyczak JB, Cannon C, Pier GB. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2:1051-1060.
31. Ma L, et al. 2009. Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog. 5:e1000354. doi:10.1371/journal.ppat.1000354.
32. Ma L, Jackson KD, Landry RM, Parsek MR, Wozniak DJ. 2006. Analysis of Pseudomonas aeruginosa conditional Psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J. Bacteriol. 188:8213-8221.
33. Manefield M, et al. 1999. Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein. Microbiology 145:283-291.
34. Manefield M, et al. 2002. Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover. Microbiology 148:1119-1127.
35. Marcotte L, Kegelaer G, Sandt C, Barbeau J, Lafleur M. 2007. An alternative infrared spectroscopy assay for the quantification of polysaccharides in bacterial samples. Anal. Biochem. 361:7-14.
36. Masuko T, et al. 2005. Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Anal. Biochem. 339:69-72.
37. Matsukawa M, Greenberg EP. 2004. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J. Bacteriol. 186:4449-4456.
38. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Müh U, et al. 2006. Novel Pseudomonas aeruginosa quorum-sensing inhibitors identified in an ultra-high-throughput screen. Antimicrob. Agents Chemother. 50:3674-3679.
40. Mulcahy H, O'Callaghan J, O'Grady EP, Adams C, O'Gara F. 2006. The posttranscriptional regulator RsmA plays a role in the interaction between Pseudomonas aeruginosa and human airway epithelial cells by positively regulating the type III secretion system. Infect. Immun. 74:3012-3015.
41. Pesci EC, Pearson JP, Seed PC, Iglewski BH. 1997. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 179:3127-3132.
42. Pessi G, et al. 2001. The global posttranscriptional regulator RsmA modulates production of virulence determinants and N-acylhomoserine lactones in Pseudomonas aeruginosa. J. Bacteriol. 183:6676-6683.
43. Richards JJ, Ballard TE, Huigens RW, III, Melander C. 2008. Synthesis and screening of an oroidin library against Pseudomonas aeruginosa biofilms. Chembiochem 9:1267-1279.
44. Roy-Burman A, et al. 2001. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183:1767-1774.
45. Ryder C, Byrd M, Wozniak DJ. 2007. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr. Opin. Microbiol. 10:644-648.
46. Schuster M, Greenberg EP. 2007. Early activation of quorum sensing in Pseudomonas aeruginosa reveals the architecture of a complex regulon. BMC Genomics 8:287. doi:10.1186/1471-2164-8-287.
47. Schuster M, Lostroh CP, Ogi T, Greenberg EP. 2003. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J. Bacteriol. 185:2066-2079.
48. Singh R, Paul D, Jain RK. 2006. Biofilms: implications in bioremediation. Trends Microbiol. 14:389-397.
49. Skindersoe ME, et al. 2008. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52:3648-3663.
50. Stewart PS, Costerton JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
51. Vannini A, et al. 2002. The crystal structure of the quorum sensing protein TraR bound to its autoinducer and target DNA. EMBO J. 21:4393-4401.
52. Ventre I, et al. 2006. Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc. Natl. Acad. Sci. U. S. A. 103:171-176.
53. Venturi V. 2006. Regulation of quorum sensing in Pseudomonas. FEMS Microbiol. Rev. 30:274-291.
54. Wade DS, et al. 2005. Regulation of Pseudomonas quinolone signal synthesis in Pseudomonas aeruginosa. J. Bacteriol. 187:4372-4380.
55. Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH. 2003. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J. Bacteriol. 185:2080-2095.
56. Whiteley M, Lee KM, Greenberg EP. 1999. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 96:13904-13909.
57. Reference deleted.
58. Yamazaki A, et al. 2012. Derivatives of plant phenolic compound affect the type III secretion system of Pseudomonas aeruginosa via a GacS-GacA two-component signal transduction system. Antimicrob. Agents Chemother. 56:36-43.
59. Zeng X, et al. 2011. Synergistic effect of 14-alpha-lipoyl andrographolide and various antibiotics on the formation of biofilms and production of exopolysaccharide and pyocyanin by Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55:3015-3017.
60. Zeng Z, et al. 2008. Virtual screening for novel quorum sensing inhibitors to eradicate biofilm formation of Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 79:119-126.
61. Zhang L, et al. 2005. Exploring novel bioactive compounds from marine microbes. Curr. Opin. Microbiol. 8:276-281.
62. Zhang L, Arnold LD. 2005. Integrated approaches for discovering novel drugs from microbial natural products, p 33-56. In Zhang LX, Arnold LD (ed), Natural products: drug discovery and therapeutics medicines. Humana Press Inc, Totowa, NJ.
63. Zhang L, et al. 2007. High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc. Natl. Acad. Sci. U. S. A. 104:4606-4611.